Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$734M |
| 2 |
Boeing
BA
|
+$493M |
| 3 |
Pfizer
PFE
|
+$478M |
| 4 |
UnitedHealth
UNH
|
+$440M |
| 5 |
Honeywell
HON
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.05B |
| 2 |
Advanced Micro Devices
AMD
|
+$447M |
| 3 |
TSMC
TSM
|
+$441M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 5 |
ExxonMobil
XOM
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.34% |
| 2 | Technology | 16.84% |
| 3 | Consumer Discretionary | 12.66% |
| 4 | Industrials | 10.11% |
| 5 | Consumer Staples | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KLRS
2101
Kalaris Therapeutics
KLRS
$103M
| $1.76M | ﹤0.01% |
19,470
+1,479
| +8% | +$188K |
|
2102
United-Guardian
UG
$33.3M
| $1.76M | ﹤0.01% |
187,463
-2,200
| -1% | -$23.8K |
|
2103
Vanguard Global ex-US Real Estate ETF
VNQI
$3.53B
| $1.76M | ﹤0.01% |
43,400
+17,700
| +69% | +$748K |
|
2104
Espey Mfg & Electronics Corp
ESP
$185M
| $1.76M | ﹤0.01% |
86,912
+3,900
| +5% | +$69.3K |
|
2105
MGIC Investment
MTG
$6.33B
| $1.75M | ﹤0.01% |
+130,800
| New | +$1.76M |
|
2106
BioXcel Therapeutics
BTAI
$27.2M
| $1.75M | ﹤0.01% |
+5,875
| New | +$2.51M |
|
|
PRO
2107
DELISTED
PROS Holdings
PRO
| $1.75M | ﹤0.01% |
63,900
+23,700
| +59% | +$617K |
|
|
CVT
2108
DELISTED
Cvent Holding Corp. Common Stock
CVT
| $1.75M | ﹤0.01% |
209,100
+160,500
| +330% | +$1.16M |
|
2109
First Trust Smith Unconstrained Bond ETF
UCON
$3.28B
| $1.74M | ﹤0.01% |
+72,000
| New | +$1.75M |
|
2110
Thryv Holdings
THRY
$113M
| $1.74M | ﹤0.01% |
75,500
+40,500
| +116% | +$906K |
|
2111
Walker & Dunlop
WD
$1.79B
| $1.74M | ﹤0.01% |
22,800
+8,900
| +64% | +$772K |
|
2112
PC Connection
CNXN
$2.22B
| $1.74M | ﹤0.01% |
38,600
-4,700
| -11% | -$214K |
|
2113
iShares MSCI Emerging Markets ETF
EEM
$29.6B
| $1.73M | ﹤0.01% |
43,900
-91,300
| -68% | -$3.63M |
|
2114
Wheels Up
UP
$212M
| $1.73M | ﹤0.01% |
13,675
+4,274
| +45% | +$948K |
|
2115
Galicia Financial Group
GGAL
$7.94B
| $1.73M | ﹤0.01% |
157,400
+32,700
| +26% | +$404K |
|
2116
World Acceptance Corp
WRLD
$899M
| $1.73M | ﹤0.01% |
+20,725
| New | +$1.81M |
|
|
PFIE
2117
DELISTED
Profire Energy, Inc
PFIE
| $1.73M | ﹤0.01% |
1,391,795
-185,440
| -12% | -$214K |
|
2118
H.B. Fuller
FUL
$3.15B
| $1.73M | ﹤0.01% |
+25,200
| New | +$1.76M |
|
2119
John Wiley & Sons Class A
WLY
$2.73B
| $1.73M | ﹤0.01% |
44,500
-69,400
| -61% | -$2.96M |
|
2120
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.79B
| $1.72M | ﹤0.01% |
25,400
+100
| +0.4% | +$6.83K |
|
|
CBL
2121
CBL Properties
CBL
$1.77B
| $1.72M | ﹤0.01% |
67,200
+24,700
| +58% | +$631K |
|
2122
Heron Therapeutics
HRTX
$100M
| $1.72M | ﹤0.01% |
1,140,836
+814,336
| +249% | +$2.04M |
|
|
CMRX
2123
DELISTED
Chimerix, Inc.
CMRX
| $1.72M | ﹤0.01% |
1,365,771
+708,976
| +108% | +$1.16M |
|
2124
Asure Software
ASUR
$249M
| $1.72M | ﹤0.01% |
+118,500
| New | +$1.4M |
|
2125
Alta Equipment Group
ALTG
$243M
| $1.71M | ﹤0.01% |
108,000
+56,900
| +111% | +$955K |
|
Similar funds
Renaissance Technologies's Q1 2023 Portfolio in Review
As of Q1 2023, Renaissance Technologies held 4,600 positions worth $75.4B, up 3.1% from $73.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2023 filing shows 524 new, 1,665 increased, 1,689 reduced and 668 closed positions. Its largest new stake was Honeywell: 1,937,917 shares worth $349M. The largest sale was Apple, an estimated $1.05B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q1 2023 buy was Honeywell: 1,937,917 shares worth $349M.
- Renaissance Technologies added most to First Republic Bank in Q1 2023, an estimated $734M increase.
- Renaissance Technologies's biggest Q1 2023 reduction was Apple, cutting an estimated $1.05B.
- Renaissance Technologies fully exited Advanced Micro Devices in Q1 2023, selling an estimated $447M.
- Renaissance Technologies's ten largest holdings make up 11% of its $75.4B portfolio in Q1 2023.
- Renaissance Technologies opened 524 new positions and closed 668 in Q1 2023.
- Renaissance Technologies's portfolio value rose 3.1% quarter-over-quarter to $75.4B.
Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.